Leonard L. Mazur - Dec 12, 2024 Form 4 Insider Report for CITIUS ONCOLOGY, INC. (CTOR)

Role
Chief Executive Officer, Director
Signature
/s/ Lorna A. Knick, by Power of Attorney
Stock symbol
CTOR
Transactions as of
Dec 12, 2024
Transactions value $
$0
Form type
4
Date filed
12/16/2024, 04:05 PM
Previous filing
Nov 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTOR Stock Option (Right to Buy) Award $0 +800K $0.00 800K Dec 12, 2024 Common Stock 800K $1.07 Direct F1
holding CTOR Stock Option (Right to Buy) 3.7M Dec 12, 2024 Common Stock 3.7M $2.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date.
F2 These options vest over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services Continuous Service to the Company as of each such vesting date.